APA Citatie

Sveen, K. A., Bech Holte, K., Svanteson, M., Hanssen, K. F., Nilsson, J., Bengtsson, E., & Julsrud Berg, T. (2021). Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes. Diabetes Care.

Chicago Style citaat

Sveen, Kari Anne, Kristine Bech Holte, Mona Svanteson, Kristian F. Hanssen, Jan Nilsson, Eva Bengtsson, en Tore Julsrud Berg. "Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes." Diabetes Care 2021.

MLA citatie

Sveen, Kari Anne, et al. "Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes." Diabetes Care 2021.